G1 Therapeutics, Inc.
SEC CIK 1560241 · GTHX · last insider filing 2024-09-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Muir Glenn P | Director | filed 2017 - 2024 |
| Secor Alicia | Director | filed 2021 - 2024 |
| Nicholson Garry A | Director | filed 2018 - 2024 |
| Schwalm Cynthia | Director | filed 2018 - 2024 |
| Bailey John E. (Jack) Jr. | Director · President and CEO | filed 2020 - 2024 |
| Lee Jacks | Director | filed 2022 - 2024 |
| Sharpless Norman | Director | filed 2022 - 2024 |
| Velleca Mark A. | Director · President and CEO | filed 2017 - 2023 |
| Deese Willie A | Director | filed 2018 - 2022 |
| Rudnick Seth | Director | filed 2017 - 2021 |
| Eshelman Fredric N | Director | filed 2017 - 2020 |
| Witty Andrew | Director | filed 2017 - 2019 |
| Shaffer Christy L | Director | filed 2017 - 2017 |
| RA Capital Management, LLC | Director | filed 2017 - 2017 |
| Sullivan Timothy Eugene | Director | filed 2017 - 2017 |
| Rivers Tyrell | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Murdock Terry L | SVP of Development Operations | filed 2017 - 2024 |
| Malik Rajesh | Chief Medical Officer | filed 2017 - 2024 |
| Avagliano Mark | Chief Business Officer | filed 2019 - 2024 |
| Perry Andrew | Chief Commercial Officer | filed 2021 - 2024 |
| Umstead John W. V | Chief Financial Officer | filed 2023 - 2024 |
| Thomas Monica R. | General Counsel | filed 2023 - 2024 |
| Moses Jennifer K. | VP of Finance & Admin | filed 2017 - 2023 |
| Hanson James S. | General Counsel | filed 2018 - 2023 |
| Gupta Soma | Chief Commercial Officer | filed 2020 - 2021 |
| Demaree John | Chief Commercial Officer | filed 2018 - 2020 |
| Phillips Barclay A | SVP & Chief Financial Officer | filed 2017 - 2019 |
| Strum Jay | Chief Scientific Officer | filed 2017 - 2019 |
| Mossinghoff Gregory J | Chief Business Officer | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.